Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-Arm, Multi-Center Trial of EkoSonic® Endovascular System and Activase for Treatment of Acute Pulmonary Embolism (PE)

NCT01513759 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01513759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01513759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-Arm, Multi-Center Trial of EkoSonic® Endovascular System and Activase for Treatment of Acute Pulmonary Embolism (PE)
Lead sponsor
Boston Scientific Corporation
Phase
Phase 3
Overall status
Completed
Start date
June 7, 2012
Completion date
February 17, 2013
Enrollment
150 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute pulmonary embolism, massive pulmonary embolism, pulmonary embolism, pulmonary thromboembolism, sub-massive pulmonary embolism